1
Clinical Trials associated with LY-3323795Single-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3323795 in Healthy Subjects
The main purpose of this study is to investigate the safety of LY3323795 and the effects it has on the body. The study drug or placebo (sugar pill) will be given by mouth to healthy participants. The study has three parts. Each participant may only enroll in one part. The study will last 14 to 43 days, depending on the part. Screening must be completed prior to study start.
100 Clinical Results associated with LY-3323795
100 Translational Medicine associated with LY-3323795
100 Patents (Medical) associated with LY-3323795
100 Deals associated with LY-3323795